Ranibizumab for persistent diabetic macular edema after bevacizumab treatment. [electronic resource]
Producer: 20170329Description: 210-214 p. digitalISSN:- 1724-6016
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bevacizumab -- therapeutic use
- Diabetic Retinopathy -- drug therapy
- Drug Substitution
- Female
- Follow-Up Studies
- Humans
- Intravitreal Injections
- Macular Edema -- drug therapy
- Male
- Middle Aged
- Ranibizumab -- therapeutic use
- Retina -- physiopathology
- Retrospective Studies
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.